CD44 and colitis: In the current study, we found that TSG-6 released by iPSC-MSCs plays an essential role in determining the therapeutic effects of iPSC-MSCs on murine colitis by stimulating intestinal epithelial proliferation through interactions between CD44 and hyaluronic acid (HA).